BioVersys AG | WebDisclosure

PRESS RELEASE

published on 08/27/2025 at 07:00, 3 months 9 days ago

BioVersys receives EMA Orphan Designation for the combination of alpibectir and ethionamide for the treatment of tuberculosis
BioVersys receives EMA Orphan Designation for the combination of alpibectir and ethionamide for the treatment of tuberculosis. The designation provides key incentives for addressing drug resistance in TB treatment

BioVersys Tuberculosis Alpibectir EMA Orphan Designation Ethionamide
BRIEF

published on 07/02/2025 at 07:05, 5 months 3 days ago

BioVersys et Shionogi collaborent sur le candidat clinique NTM

Commercialisation Mondiale Collaboration BioVersys Partenariat Shionogi Candidat Clinique NTM Plateforme Ansamycine
BRIEF

published on 07/02/2025 at 07:05, 5 months 3 days ago

BioVersys and Shionogi Collaborate on NTM Clinical Candidate

Global Commercialization BioVersys Collaboration Shionogi Partnership NTM Clinical Candidate Ansamycin Platform
PRESS RELEASE

published on 07/02/2025 at 07:00, 5 months 3 days ago

BIOVERSYS AND SHIONOGI ENTER INTO GLOBAL RESEARCH COLLABORATION FOR BROAD-SPECTRUM NON-TUBERCULOUS MYCOBACTERIA (NTM) CLINICAL CANDIDATE
BioVersys and Shionogi enter global research collaboration for NTM clinical candidate. BioVersys grants Shionogi license option for leads from BV500 program

Shionogi BioVersys Global Research Collaboration NTM Clinical Candidate
BRIEF

published on 06/30/2025 at 07:05, 5 months 5 days ago

L'assemblée générale annuelle de BioVersys AG donne des résultats positifs

États Financiers Élections Du Conseil D'administration Initiatives Stratégiques Assemblée Générale Annuelle De BioVersys Amendement Capital
BRIEF

published on 06/30/2025 at 07:05, 5 months 5 days ago

BioVersys AG Annual General Meeting Yields Positive Outcomes

Financial Statements Strategic Initiatives Board Elections BioVersys AGM Capital Amendment
PRESS RELEASE

published on 06/30/2025 at 07:00, 5 months 5 days ago

BIOVERSYS ANNOUNCES RESULTS FROM its ANNUAL GENERAL MEETING OF SHAREHOLDERS
BioVersys AG announces results from its Annual General Meeting of Shareholders, including re-election of Board Members and amendment to capital range for strategic initiatives

Annual General Meeting Shareholders Board Members BioVersys AG Capital Range
BRIEF

published on 06/03/2025 at 07:05, 6 months 2 days ago

BioVersys Announces 2025 Annual General Meeting of Shareholders

Capital Increase Board Elections Shareholders Meeting 2025 AGM BioVersys AG
BRIEF

published on 06/03/2025 at 07:05, 6 months 2 days ago

BioVersys annonce l'assemblée générale annuelle des actionnaires de 2025

Augmentation De Capital Élections Du Conseil D'administration Assemblée Générale Des Actionnaires Assemblée Générale Annuelle 2025 BioVersys AG
PRESS RELEASE

published on 06/03/2025 at 07:00, 6 months 2 days ago

BioVersys publishes Invitation to its ANNUAL GENERAL MEETING OF SHAREHOLDERS 2025
BioVersys AG publishes Invitation to its Annual General Meeting of Shareholders 2025, including agenda with items such as annual report, elections, compensation approval, and capital range amendment

Annual General Meeting Shareholders Biopharmaceutical AGM 2025 BioVersys AG

Published on 12/05/2025 at 02:35, 6 hours 46 minutes ago

Future Fuels Initates Drill Permitting at Hornby; Marketing Update
Published on 12/05/2025 at 02:30, 6 hours 51 minutes ago

Klondike Gold Announces AGM Results
Published on 12/05/2025 at 01:00, 8 hours 21 minutes ago

BEACN Closes First Tranche of Non-Brokered Private Placement
Published on 12/04/2025 at 23:05, 10 hours 16 minutes ago

BlackBerry to Announce Third Quarter Fiscal Year 2026 Results on December 18, 2025
Published on 12/04/2025 at 23:00, 10 hours 21 minutes ago

NXT Energy Solutions Completes Data Acquisition for SFD Survey

View all ACCESSWIRE

Published on 12/05/2025 at 09:05, 16 minutes ago

Transforming Football: IBM and Bayer 04 Leverkusen Use AI for Superior Game Analysis
Published on 12/05/2025 at 09:00, 21 minutes ago

Original-Research: DEMIRE AG (von NuWays AG): BUY
Published on 12/05/2025 at 09:00, 21 minutes ago

SPECTRIS PLC - Removal
Published on 12/05/2025 at 09:00, 21 minutes ago

Official List Notice
Published on 12/05/2025 at 09:00, 21 minutes ago

Petershill Partners plc - Removal

View all EQS

Published on 12/05/2025 at 08:45, 36 minutes ago

Air Liquide va étendre et électrifier son unité de production d'oxygène à Shaanxi, soutenant ainsi l'engagement de la Chine à décarboner son industrie
Published on 12/05/2025 at 08:45, 36 minutes ago

Air Liquide to expand and electrify its oxygen facility in Shaanxi, supporting China’s commitment to decarbonize its industry
Published on 12/05/2025 at 08:42, 39 minutes ago

ENGIE - déclaration mensuelle du nombre total d'actions et de droits de vote composant le capital au 30 novembre 2025
Published on 12/04/2025 at 18:14, 15 hours 7 minutes ago

Résiliation d'une convention conclue entre actionnaires
Published on 12/04/2025 at 18:00, 15 hours 21 minutes ago

Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 28 novembre 2025

View all LES ECHOS COMFI WIRE

News